LOGIN  |  REGISTER
Chimerix
C4 Therapeutics

Universal Health Services to Present at 45th Annual Goldman Sachs Global Healthcare Conference

June 07, 2024 | Last Trade: US$174.80 1.14 0.66

KING OF PRUSSIA, Pa., June 7, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will participate in a fireside chat at the 45th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2024, at 4:00pm (ET).

A live audio webcast of the presentation will be available on the Company's website (www.uhs.com). For those unable to listen to the live webcast, a replay of the presentation will be available on the Company's website for 90 days following the conference.

Universal Health Services, Inc. ("UHS") is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico and the United Kingdom.

Assertio

Stock Quote

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page